Le Lézard
Classified in: Health, Science and technology, Business
Subjects: DIV, ACC

Tobii Dynavox revises financial targets


STOCKHOLM, Feb. 21, 2024 /PRNewswire/ -- Tobii Dynavox AB, (publ) ("Tobii Dynavox") the world leader in assistive communication, today announced revised financial targets and dividend policy. According to the new targets, Tobii Dynavox expects to grow revenue on average by 20% yearly and deliver an EBIT margin that reaches and exceeds 15%.

The Board of Directors of Tobii Dynavox has revised the financial targets and dividend policy to better align with the company's current performance and outlook.

The updated financial targets, with a time horizon of 3-4 years are:

The revised dividend policy is to distribute at least 40% of available net profits to shareholders in the form of dividends, share repurchases or comparable measures.

Fredrik Ruben, CEO of Tobii Dynavox comments: "Since we set our previous financial targets in 2021, the company and the market have continued to develop in a way that is favorable to us. Our financial position is strengthened, we are growing significantly faster than before, and we have solid confidence in our improving profitability trend. Entering this new phase in the company's development, distribution of profits to shareholders also becomes relevant."

More information about the revised targets will be given at the Capital Markets Day that Tobii Dynavox is hosting today, February 21, 2024 at 09:00 CET in Stockholm. A recording of the presentation along with all material will be published on our Investor Relations website on February 22.

For reference:
The previous targets that are now being replaced read:

This information is information that Tobii Dynavox AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted, through the agency of the contact person set out below, for publication at 08:00 CET, on February 21, 2024.

Contact

Linda Tybring, CFO, Tobii Dynavox, phone: +46 (0) 7068 14 980, email: [email protected] 

The following files are available for download:

https://mb.cision.com/Main/11919/3932719/2618346.pdf

Press release Tobii Dynavox revises financial targets

SOURCE Tobii Dynavox


These press releases may also interest you

26 avr 2024
The report titled "Anti-Mullerian Hormone Test Market by Product (POC Testing, Self-check Kits), End-User (Commercial Labs, Research & development), Distribution, Use - Global Forecast 2024-2030" is now available on 360iResearch.com's offering,...

26 avr 2024
Rakovina Therapeutics Inc. a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies announced the financial results for its fourth quarter and fiscal year ending December 31, 2023 and...

26 avr 2024
ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines, today announced its ongoing commitment to exploring the therapeutic opportunity of glycobiology through support for ongoing research at GanNA Bio, and the...

26 avr 2024
Appili Therapeutics Inc. (the "Company" or "Appili"), a biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures, today announced it has secured additional bridge financing in the amount of C$300,000...

26 avr 2024
David J. Dykeman, co-chair of the Life Sciences & Medical...

26 avr 2024
Aspire Health Alliance ("Aspire Health") is a company headquartered in Braintree, Massachusetts, that provides behavioral health services in the community.  Aspire Health experienced a data security incident that may have involved personal and...



News published on and distributed by: